BioSpace News Archive

Business

CENTOGENE Expands Executive Leadership Team

CENTOGENE announced the expansion of its executive leadership team with the appointment of Sun Kim in Boston, MA asChief Strategy & Investor Relations Officer.

May 9, 2019
·
2 min read
Pharm Country

Merck’s Pneumococcal Vaccine for Babies Looks Good in Trial

Merck and Co. announced that its investigational 15-valent pneumococcal conjugate vaccine was “noninferior” to a currently available 13-valent pneumococcal conjugate vaccine in healthy babies 6 to 12 weeks of age.

May 9, 2019
·
3 min read
·
Mark Terry
Job Trends

Merck to Invest $1 Billion in Virginia Facility, Add 100 Jobs

Merck is planning a $1 billion expansion to its manufacturing facility in Elkton, Va. over the course of the next three years that will include the addition of approximately 100 new jobs, the office of the governor of Virginia announced Wednesday.

May 9, 2019
·
2 min read
·
Alex Keown
Job Trends

Biotech Companies Provide High Median Salaries, Analysis Shows

For young people looking to find a career path, the pharmaceutical industry is a good one to go into, especially if salary is a major concern.

May 9, 2019
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: May 10

Pharma and biotech companies strengthen their leadership teams with new hires at Immunocore, Eisai, Kyn, Bicycle, and more.

May 9, 2019
·
4 min read
·
Alex Keown
Drug Development

Research Roundup: Cancer Metastasis, Marathon Training, Fibromyalgia and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

May 9, 2019
·
6 min read
·
Mark Terry
Business

Eisai and UK Dementia Research Institute Jointly Launch New Post-Doctoral Programme to Accelerate Dementia Research

Eisai Co., Ltd. and the UK Dementia Research Institute announced the launch of a joint post-doctoral programme to support the advancement of novel dementia research.

May 9, 2019
·
4 min read
Drug Development

Bristol-Myers Squibb’s Opdivo Fails in Brain Cancer Trial

The company announced today that the drug failed to meet its primary endpoint in patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme (GBM), a type of brain cancer.

May 9, 2019
·
3 min read
·
Mark Terry
Deals

4 Biotech Companies List on the Nasdaq Today

Four biotech companies began trading on the Nasdaq this morning. Here’s a look at today’s launches and one rumored IPO.

May 9, 2019
·
4 min read
·
Mark Terry
Expedeon AG adds ELISA-ONE™ next generation cell signalling assay technology to product offering

Technology developed by Expedeon company TGR BioSciences

May 9, 2019
·
4 min read